AstraZeneca’s share price has fallen a long way from its record-breaking level last year, which indicates that I may be ...

The AstraZeneca PLC ADR AZN slipped 0.55% to $65.37 Tuesday, on what proved to be an all-around mixed trading session for the ...

NDAQ:AZN) AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information ...

AstraZeneca PLC (AZN) stock saw a decline, ending the day at $65.73 which represents a decrease of $-1.28 or -1.91% from the prior close of $67.01. The stock opened at $65.88 and touched a low of $65.

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In this article, we are going ...

This latest approval for Orpathys in NSCLC makes the drug available in both the first- and second-line settings.

Shares of AstraZeneca PLC AZN slipped 1.77% to £106.30 Tuesday, on what proved to be an all-around poor trading session for ...

This writer currently owns 14 different FTSE 100 shares in his portfolio. Here's a quick look at what they are and why he ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

The evidence sessions this week will begin with opening statements from the core participants, followed by evidence from representatives of bereaved families, as well as vaccine injury groups. Mr ...

In a pooled analysis from two trials, Dato-DXd has shown promise as a treatment for advanced EGFR-mutated NSCLC.

SAN FRANCISCO (Reuters) - Philips CEO Roy Jakobs said he still expects subdued demand in China this year due to healthcare ...